🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,070.00
-220.00 (-3.50%)
Nov 20, 2026, 3:30 PM KST

Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 585.78 billion as of November 20, 2026. It is the 14,678th most valuable company in the world and the 380th biggest in South Korea. Its market cap has increased by 28.27% in one year.

Market Cap
585.78B
Enterprise Value
565.99B
Revenue
3.32B
Global Rank
Country Rank
#380 South Korea
PE Ratio
n/a

Chart

Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 585.78B, an increase of 1,133.36%. That is a compound annual growth rate of 11.17%.

History

DateMarket Cap% Change
Nov 20, 2026585.78B22.85%
Dec 30, 2025476.83B-15.13%
Dec 30, 2024561.85B-45.92%
Dec 28, 20231.04T-4.44%
Dec 29, 20221.09T11.39%
Dec 30, 2021976.10B-6.92%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Kolon TissueGene989.90B
Chabiotech678.97B
Proteina654.39B
Komipharm International600.20B
Pharmicell470.43B
AbClon469.87B
Onconic Therapeutics463.61B
Medy-Tox457.24B
Market Cap Rankings